Hysen (Hangzhou) Biotech Showcases Latest IVD Products at CMEF 2023

The 87th China International Medical Equipment Fair (CMEF), held from May 14 to May 17, 2023, at the Shanghai National Exhibition and Convention Center.

Hangzhou, China - Hysen (Hangzhou) Biotech CO.,LTD, a leading producer and supplier of in vitro diagnostic (IVD) products, was among the participants at the 87th China International Medical Equipment Fair (CMEF), held from May 14 to May 17, 2023, at the Shanghai National Exhibition and Convention Center.

Under the theme "Innovative Technology, Smart Future," this year's CMEF, a flagship platform for global medical technology and industry policy trends, brought together more than 5,000 companies from over 20 countries and regions, showcasing tens of thousands of cutting-edge products. Over 1,000 industry leaders and experts attended the event, while international visitors from over 100 countries gathered to explore business opportunities in the global medical field.

Hysen's presence at CMEF 2023 was a testament to the company's commitment to innovation and leadership in IVD product manufacturing. With over a decade of experience in the industry, Hysen is renowned for its advanced technology and high-quality products, including immunofluorescence assays (IFAs), chemiluminescent immunoassays (CLIAs), and enzyme-linked immunosorbent assays (ELISAs).

At the fair, Hysen showcased its latest products, including the Hysen IFA Analyzer andHysen CLIA Analyzer, which offer high sensitivity and accuracy in the detection of various infectious diseases, such as COVID-19, hepatitis B, and HIV. The Hysen IFA Analyzer features a user-friendly interface and automated operation, providing fast and reliable results for clinical diagnosis and research. The Hysen CLIA Analyzer, on the other hand, adopts a chemiluminescent detection method, which offers superior sensitivity and specificity compared to traditional immunoassays.

Visitors to Hysen's booth at CMEF 2023 were impressed by the company's innovative products and cutting-edge technology, as well as its commitment to quality and customer satisfaction. Hysen's team of experts was on hand to provide information and technical support, as well as to discuss potential collaborations and partnerships with interested parties.

As the global demand for IVD products continues to grow, Hysen is poised to expand its market share and strengthen its position as a leading player in the industry. With a focus on innovation, quality, and customer service, Hysen is well-equipped to meet the evolving needs of healthcare providers and patients worldwide.

In conclusion, Hysen's participation in CMEF 2023 was a great success, showcasing the company's advanced technology and commitment to excellence. As Hysen continues to push the boundaries of IVD product development, it is poised to make a significant contribution to the global medical industry and improve the lives of patients around the world.